NCT06036446 (LATCH) is a NA clinical trial of Cervical cerclage in Premature Birth, sponsored by Thomas Jefferson University.

Who is sponsoring NCT06036446?

NCT06036446 is sponsored by Thomas Jefferson University.

What drugs are being tested in NCT06036446?

Interventions in NCT06036446: Cervical cerclage, Vaginal Suppository Progesterone.

What condition does NCT06036446 study?

NCT06036446 studies Premature Birth.

Is NCT06036446 still recruiting?

NCT06036446 is currently recruiting now. Last updated 27 May 2026.

Last reviewed 2026-05-27 · How we verify

NCT06036446: LATCH

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cervical Cerclage for Short Cervix at 24-26 Weeks of Gestation: a Randomized Controlled Trial

Recruiting now NA Last updated 27 May 2026

What this trial tests

NA trial testing Cervical cerclage in Premature Birth in 329 participants. Currently enrolling.

Timeline

10 November 2023

Primary endpoint
1 October 2028

1 February 2029

Quick facts

Lead sponsor	Thomas Jefferson University
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	329
Start date	10 November 2023
Primary completion	1 October 2028
Estimated completion	1 February 2029
Sites	2 locations across United States

Drugs / interventions tested

Cervical cerclage
Vaginal Suppository Progesterone — full drug profile →

Conditions studied

Premature Birth — all drugs for Premature Birth →

Sponsor

Thomas Jefferson University

Who can join

Adults 18 to 50, female only, with Premature Birth. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Incidence of preterm birth <37 weeks
Time frame: At delivery

Sponsor's own description

The goal of this clinical trial is to determine whether cervical cerclage reduces the risk of preterm birth in patients with a short transvaginal ultrasound (TVU) cervical length (CL) ≤25mm between 24 0/7-26 6/7 weeks.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Cervical cerclage

Trials testing the same drug.

NCT07372495 — Cerclage Plus Progesterone vs Progesterone Alone in Twin Short Cervix · NA · not yet recruiting
NCT05334264 — Prophylactic Cervical Cerclage in Twin Pregnancies With Non-shortened Cervix · NA · unknown
NCT04151303 — The Optimal Timing for Cerclage Removal · unknown
NCT03863613 — Pessary Versus Cerclage With or Without Progesterone in Twins · NA · terminated
NCT03781466 — Effect of Cervical Cerclage With Vaginal Progesterone in Asymptomatic Twin Pregnancies With a Sonographic Short Cervix · NA · unknown

Other recruiting trials for Premature Birth

Currently open trials in the same condition.

NCT07490912 — Neonatal Data and Biobank to Study Factors Influencing Development in Preterm Infants Born at <32 Weeks' Gestation and/o · recruiting
NCT07183462 — Azithromycin and Ampicillin for Late PPROM · Phase 4 · recruiting
NCT07306793 — The Effect of PIOMI and Chronobiological Nutrition on Readiness for Feeding, Full Transition to Oral Feeding and Body We · NA · recruiting
NCT06554522 — Pragmatic Evaluation of Respiratory Distress Syndrome Treatment in Africa · Phase 4 · recruiting
NCT06340971 — Air Pollution and Pregnancy · recruiting

Other Thomas Jefferson University trials

Trials by the same sponsor.

NCT07526480 — Improving Dementia Care in Primary Practice · NA · not yet recruiting
NCT07414550 — Radiotherapy for Refractory Hidradenitis Suppurativa · NA · not yet recruiting
NCT07402018 — Intra-aortic Balloon Counterpulsation (IABC) Compliance · recruiting
NCT07217197 — Respiratory Monitoring System That Detects & Predicts OIRD · NA · enrolling by invitation
NCT07145099 — The IMPACT Study: Personalized Physical Therapy for Better Recovery and a Stronger Core After Hernia Surgery · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06036446 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Thomas Jefferson University
Last refreshed: 27 May 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06036446.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing